Cordant, Inc. Organogenesis Holdings Inc. Transaction History
Cordant, Inc.
- $190 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$62.3 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$25.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$17.9 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$15.4 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $653M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...